G
GeneDx Holdings Corp. (WGS)
NMS – Real Time Price. Currency in USD
69.82
+1.15 (1.67%)
At close: Jun 26, 2026, 4:00 PM EDT
68.70
-1.12 (-1.60%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
69.82
+1.15 (1.67%)
At close: Jun 26, 2026, 4:00 PM EDT
68.70
-1.12 (-1.60%)
After-hours: Jun 26, 2026, 7:58 PM EDT
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
| Name | Position |
|---|---|
| Dr. Bryan M. Dechairo Ph.D. | Chief Operating Officer |
| Mr. Kevin Feeley CPA | Chief Financial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-06-23 | 8-K | wgs-20260618.htm |
| 2026-06-16 | 8-K | wgs-20260615.htm |
| 2026-05-04 | 8-K | wgs-20260504.htm |
| 2026-05-04 | 10-Q | wgs-20260331.htm |
| 2026-04-30 | DEF 14A | wgs-20260430.htm |
| 2026-03-02 | 8-K | wgs-20260227.htm |
| 2026-02-23 | S-8 | s-82026evergreen.htm |
| 2026-02-23 | 8-K | wgs-20260223.htm |
| 2026-01-12 | 8-K | wgs-20260112.htm |
| 2025-10-28 | S-3ASR | genedx-sx3asr.htm |